Home > News > Nanotechnology and Cancer
September 1st, 2004
Abstract:
"The NCI Alliance for Nanotechnology in Cancer is a national initiative that will enable us to join together all the communities in the public and private sector that provide discovery, innovation and development expertise in nanotechnology applied to cancer. The Alliance is built on a strong foundation of science and scientific accomplishment. Its implementation will be guided by the Cancer Nanotechnology Plan."
Catch the live webcast on September 13, 2004, 1:00 P.M. - 2:30 P.M. EDT.
Speakers include:
- Dr. Vicki Colvin, Executive Director of the Center for Biological and Environmental Nanotechnology and Associate Professor of Chemistry, Rice University
- Dr. Janet Woodcock, Director, FDA Center for Drug Evaluation and Research
- Dr. Andrew von Eschenbach, Director, NCI
- Dr. Samuel Wickline, Director of Cardiology, Washington University
- Dr. Mauro Ferrari, Special Expert to the NCI on Nanotechnology and Professor of Biomedical Engineering, Ohio State University
Source:
NCI Alliance
Bookmark:
| Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Announcements
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Finding quantum order in chaos May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||